Here is part of your question answered: The lates
Post# of 36536
(Total Views: 432)
Posted On: 03/09/2022 9:19:54 AM
Here is part of your question answered:
The latest study enrolled 2,247 U.S. kids ages 12 to 17 last summer and found the two-dose vaccine was 80% effective at preventing symptomatic COVID-19 infection
https://www.modernhealthcare.com/supply-chain...s-young-12
What they have found in the MRna vaccines is that 12-17 is 7 times more likely to experience myocarditis and end up with severe issues from getting covid and from 5-12 the MRna vaccines is only 11% effective so more likely to experience adverse reactions to vaccine than it help them
The latest study enrolled 2,247 U.S. kids ages 12 to 17 last summer and found the two-dose vaccine was 80% effective at preventing symptomatic COVID-19 infection
https://www.modernhealthcare.com/supply-chain...s-young-12
What they have found in the MRna vaccines is that 12-17 is 7 times more likely to experience myocarditis and end up with severe issues from getting covid and from 5-12 the MRna vaccines is only 11% effective so more likely to experience adverse reactions to vaccine than it help them
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼